SHARON RHODES: Open Payments
NPI 1043391824 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 63 payments from 17 companies in 2025. Trend: 2023 $1,194 · 2024 $1,279 · 2025 $1,535
Food & beverage: $1,535
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $428 |
| ABBVIE INC. | 17 | $279 |
| Abbott Laboratories | 3 | $166 |
| Sequel Med Tech, LLC | 1 | $160 |
| Otsuka America Pharmaceutical, Inc. | 5 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $103 |
| Supernus Pharmaceuticals, Inc. | 5 | $76 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Ascensia Diabetes Care Us Inc. | 1 | $24 |
| Endo USA, Inc. | 1 | $23 |
Products named: COBENFY, VRAYLAR, FREESTYLE LIBRE 3, TWIIST, CAPLYTA, Qelbree, ABILIFY ASIMTUFII, REXULTI.
Industry payments across VA — which companies pay providers there.
